Brief: Trinity Biotech Receives Additional Orders For Trinscreen HIV
13/05/2024 16:43
May 13 (Reuters) - Trinity Biotech PLC TRIB.O :
* TRINITY BIOTECH ANNOUNCES INCREASED ORDERS FOR TRINSCREEN
HIV
AND RAISES GUIDANCE FOR 2024 TRINSCREEN HIV SALES
* TRINITY BIOTECH PLC - COMPANY HAS INCREASED ITS EXPECTED
2024
SALES REVENUE FOR TRINSCREEN HIV TO OVER $8 MILLION
* TRINITY BIOTECH- RECEIVED SUBSTANTIAL ADDITIONAL ORDERS
FOR
TRINSCREEN HIV, BRINGING TOTAL ORDERS RECEIVED TO DATE FOR
SUPPLY IN 2024 TO ABOUT $6 MILLION
Source text for Eikon: ID:nGNX91ZYkT
Further company coverage: TRIB.O
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM